Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. - Wikidata - awgldk - TriplyDB

Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.

Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.

http://www.wikidata.org/entity/Q35013317

about

OCT: New perspectives in neuro-ophthalmology Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives Reliability of Intra-Retinal Layer Thickness Estimates.Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.Longitudinal Evaluation of Visual Function in Multiple Sclerosis.Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.A window to beyond the orbit: the value of optical coherence tomography in non-ocular disease.Afferent visual pathways in multiple sclerosis: a review.Monitoring the Course of MS With Optical Coherence Tomography.Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS.The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis.Longitudinal optical coherence tomography study of optic atrophy in secondary progressive multiple sclerosis: Results from a clinical trial cohort.Progression of retinal ganglion cell loss in multiple sclerosis is associated with new lesions in the optic radiations.Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: no.Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.Use of A-scan Ultrasound and Optical Coherence Tomography to Differentiate Papilledema From Pseudopapilledema.Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.Roles of Treg/Th17 Cell Imbalance and Neuronal Damage in the Visual Dysfunction Observed in Experimental Autoimmune Optic Neuritis Chronologically.

P2860

Q27009498-A3D4349F-A802-4AB1-939C-48E272FDDB7D Q28080265-5991E37B-4970-4DAC-997A-121C75810434 Q35182733-CA0D2232-3BF8-4375-B6D2-9F84ACA7DB51 Q35766939-B4513513-3622-4E96-9246-399A8135EAD8 Q36063052-CE6D48FB-3A7A-4A7F-9B51-9A07F75FAB4F Q36090219-6DE3BBBA-9689-4EAE-A211-1B020FAC2D79 Q36218384-C159E3EE-B03F-4AD1-812B-1C41A94B72E2 Q36353053-4F7FD13D-280B-447B-AD51-503C61886CBD Q37056744-77BCB4A9-A4C2-4682-99DB-9489F86E8C9B Q38709464-6597B75F-3C73-4F7C-BF15-D7C64E07A066 Q38787395-1E5F38AB-30ED-431A-8114-DF16E8623966 Q39218152-77C2F5C6-71FD-4F14-BEB8-76C90ACF78BA Q39342993-8104559D-04B4-48F8-9ED2-4E96F6FBA3E1 Q47141682-17414595-F89E-49F3-8F24-7D736DFA3A60 Q47564729-7D0D6B29-E822-40AD-88BF-2C1B72B5C70D Q47981879-F777E39B-52CA-4698-BB00-A081EB969A7A Q48158244-4E4DA71B-16FD-44E0-8C47-62DE77667616 Q48582930-2C4DC104-47DA-427D-8408-8082A4C2F617 Q49336386-3D8035BE-148B-427A-9D3F-258201AE2D93 Q50093754-777BD541-72F2-4AFA-BA6C-8B0468AB88CD Q53173445-B7B53195-AD7B-4BC0-8EB4-B7EE62E91077 Q53363568-A5026119-C83B-4655-9DB6-9BC73BFA754E

P2860

Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis.

http://www.wikidata.org/entity/Q35013317

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tracking changes over time in ...... ickness in multiple sclerosis.

@ast

Tracking changes over time in ...... ickness in multiple sclerosis.

@en

type

label

Tracking changes over time in ...... ickness in multiple sclerosis.

@ast

Tracking changes over time in ...... ickness in multiple sclerosis.

@en

prefLabel

Tracking changes over time in ...... ickness in multiple sclerosis.

@ast

Tracking changes over time in ...... ickness in multiple sclerosis.

@en

P1433

Q35013317-69F0283F-15EB-4B13-B85E-60A99DBE5620

P1476

Q35013317-14244F46-FF81-48FD-BF01-71ECA1EC9B02

P2093

Q35013317-444BC047-2642-4810-B34F-C62B8C908D2B

Q35013317-69152B9F-8255-4DD9-BA6E-973DEE1340FB

Q35013317-888F2FDC-F168-4F45-A283-63EF4220D1E8

Q35013317-DB74D365-1EA9-40A7-A914-73EE828CE310

Q35013317-E76571F2-3DAA-46F2-9AAE-04A40667A218

Q35013317-FC3AE8E3-4973-4B99-B73B-5822697915C0

P2860

Q35013317-06380229-B870-47ED-805C-04A91448ECD4

Q35013317-18F61211-5F81-4C8E-AC58-0D0B1DF9D7C7

Q35013317-34504633-F0B5-4AEC-91F6-40B9F814FE43

Q35013317-4BDE6CDD-CA06-47FC-B9E9-19308F8E782D

Q35013317-4DF63817-711B-40FE-A8E3-ED1A2A7DB767

Q35013317-61FDBF41-A96D-4474-9C10-E7D399246C89

Q35013317-78BCF5E7-7018-4559-B805-5AAE85CD9E40

Q35013317-98AB6ECE-7D4F-4C7B-9567-001720C17A53

Q35013317-9AE336D8-DB81-4080-832F-CE95127A5AB0

Q35013317-AB3C942C-4EC3-4EB5-BE9E-A657D89B535C

P304

Q35013317-EB811472-BE99-44AF-B0C3-F848CC28481F

P31

Q35013317-CA84D35B-49F8-42DE-95E5-7A032047717E

P356

Q35013317-5CF457FB-AE96-4F45-BBDF-0AFEC9FC5074

P433

Q35013317-CBF29231-690D-4E6A-8E41-087107184197

P478

Q35013317-CBF8CDAD-5943-4833-B92E-D48840629AE7

P577

Q35013317-C77834B0-03E4-4012-97C6-3BC9EF270B4E

P698

Q35013317-F0A54BBB-1B9A-42E9-B809-4AED3E08C13E

P921

Q35013317-7EF27FB1-3D9E-4FD9-B295-DC47B855789C

P932

Q35013317-072B7566-8E37-4EC6-BBFE-C9730D048DD5

P356

1352458514523498

P1433

Multiple Sclerosis Journal

P1476

Tracking changes over time in ...... ickness in multiple sclerosis.

@en

P2093

Divya Narayanan

http://www.w3.org/2001/XMLSchema#string

Han Cheng

http://www.w3.org/2001/XMLSchema#string

Karlie N Bonem

http://www.w3.org/2001/XMLSchema#string

Laura J Frishman

http://www.w3.org/2001/XMLSchema#string

Roberto Saenz

http://www.w3.org/2001/XMLSchema#string

Rosa A Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis

Current and emerging therapies in multiple sclerosis: a systematic review

Multiple sclerosis

Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.

Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients.

Profile and predictors of normal ganglion cell-inner plexiform layer thickness measured with frequency-domain optical coherence tomography.

Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma.

Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials

P304

1331-1341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458514523498

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24639478

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

4306466

http://www.w3.org/2001/XMLSchema#string